Ligand Pharmaceuticals Inc
LGND· Nasdaq
LGNDLigand Pharmaceuticals Inc
Source filing unavailable
| Metric | Q3 2011 | Q3 2010 | Q3 2009 |
|---|---|---|---|
| Revenue | $6.38M | $5.74M | $7.80M |
| Net Income | -$194.00K | -$4.18M | -$11.84M |
| EPS Diluted | -$0.01 | -$0.21 | -$0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR
